Explore

Trendline Trendline
CereVasc Secures $85 Million Series C Financing to Advance eShunt System for Neurological Treatment

CereVasc Secures $85 Million Series C Financing to Advance eShunt System for Neurological Treatment

CereVasc Secures $85 Million Series C Financing to Advance eShunt System for Neurological Treatment
Trendline Trendline
CereVasc Secures $85 Million Series C Financing to Advance eShunt System for Hydrocephalus Treatment

CereVasc Secures $85 Million Series C Financing to Advance eShunt System for Hydrocephalus Treatment

CereVasc Secures $85 Million Series C Financing to Advance eShunt System for Hydrocephalus Treatment
Trendline Trendline
CereVasc Secures $85 Million Series C Funding to Advance eShunt System for Hydrocephalus Treatment

CereVasc Secures $85 Million Series C Funding to Advance eShunt System for Hydrocephalus Treatment

CereVasc Secures $85 Million Series C Funding to Advance eShunt System for Hydrocephalus Treatment
Trendline Trendline
CereVasc Secures $85 Million to Advance eShunt System for Hydrocephalus

CereVasc Secures $85 Million to Advance eShunt System for Hydrocephalus

CereVasc Secures $85 Million to Advance eShunt System for Hydrocephalus
Trendline Trendline
Medtronic Achieves Highest Annual Revenue Growth in a Decade

Medtronic Achieves Highest Annual Revenue Growth in a Decade

Medtronic Achieves Highest Annual Revenue Growth in a Decade
Trendline Trendline
OrthAlign, Inc. Secures FDA Clearance for Lantern ASC System, Enhancing Ambulatory Surgery Centers

OrthAlign, Inc. Secures FDA Clearance for Lantern ASC System, Enhancing Ambulatory Surgery Centers

OrthAlign, Inc. Secures FDA Clearance for Lantern ASC System, Enhancing Ambulatory Surgery Centers
Trendline Trendline
OrthAlign, Inc. Gains FDA Clearance for Lantern ASC System, Enhancing Ambulatory Surgery Centers

OrthAlign, Inc. Gains FDA Clearance for Lantern ASC System, Enhancing Ambulatory Surgery Centers

OrthAlign, Inc. Gains FDA Clearance for Lantern ASC System, Enhancing Ambulatory Surgery Centers
Trendline Trendline
Medtronic CEO Geoff Martha Discusses Growth Strategy and Robot-Assisted Surgery

Medtronic CEO Geoff Martha Discusses Growth Strategy and Robot-Assisted Surgery

Medtronic CEO Geoff Martha Discusses Growth Strategy and Robot-Assisted Surgery
Trendline Trendline
Advanced NanoTherapies Raises $31M for Dual-Drug Vascular Treatment Platform

Advanced NanoTherapies Raises $31M for Dual-Drug Vascular Treatment Platform

Advanced NanoTherapies Raises $31M for Dual-Drug Vascular Treatment Platform
Trendline Trendline
Xenix Medical Secures FDA Clearance for Riva Posterior Fixation System, Launches Commercially

Xenix Medical Secures FDA Clearance for Riva Posterior Fixation System, Launches Commercially

Xenix Medical Secures FDA Clearance for Riva Posterior Fixation System, Launches Commercially
Trendline Trendline
Coloplast's Titan Prime Inflatable Penile Prosthesis Approved by FDA, Aiding Men with Erectile Dysfunction

Coloplast's Titan Prime Inflatable Penile Prosthesis Approved by FDA, Aiding Men with Erectile Dysfunction

Coloplast's Titan Prime Inflatable Penile Prosthesis Approved by FDA, Aiding Men with Erectile Dysfunction
Trendline Trendline
Facet Life Sciences Appoints Frank A. Closurdo as VP to Enhance Regulatory and Market Guidance

Facet Life Sciences Appoints Frank A. Closurdo as VP to Enhance Regulatory and Market Guidance

Facet Life Sciences Appoints Frank A. Closurdo as VP to Enhance Regulatory and Market Guidance